Pharmaceutical Contract Development and Manufacturing Organization Market: By Service, By End User and Geography  

Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Size, Share, Growth, Trends, and Global Industry Analysis: By Service (Pharmaceutical Manufacturing Services, Drug Development Services and Biologics Manufacturing Services), By End User (Small & Mid-Size Pharma, Generic Pharmaceutical Companies, Big Pharma and Other End Users) and Region  

Pharmaceutical Contract Development And Manufacturing Organization Market size was valued at 92.1 billion in 2022 and is expected to reach 145.0 million by 2029, at a CAGR of 6.7% from 2022 to 2028.  Some of the key factors fueling the market growth include increasing investments in pharmaceutical R&D, advent of CDMO model into the outsourcing model, growing subcontracting volume by big pharmaceutical companies and rising healthcare standards in developing countries,. However, increasing lead time and logistics costs, stringent regulatory requirements and changing trade policies between countries are hindering the market growth. In addition, increasing outsourcing of clinical trials to emerging markets and growing focus on specialty medicines provides huge growth opportunity for the market.

The report studies global market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the global market report includes human demographics; regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed global pharmaceutical contract development and manufacturing organization market to better equip clients with possible investment opportunities across the regions (regional Investment Hot-Spots) and market unmet needs (Product opportunities). Key stakeholders of the global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market report include suppliers, manufacturers, marketers, policy makers, and healthcare service providers engaged in global pharmaceutical contract development and manufacturing organization (CDMO) products.

Pharmaceutical Contract Development And Manufacturing Organization Market Key Developments:
  • In February 2022, Recipharm acquired Portuguese CDMO GenIbet, specializes in producing biological clinical trial material and other viral vectors to expand its biologics operations with a focus on drug substance production for advanced products. In December 2021, SGS acquired Quay Pharmaceuticals Limited to provide extensive range of support and services to its clients.

Global Pharmaceutical Contract Development And Manufacturing Organization Cdmo Market Summary

Study Period

2024-2030

Base Year

2023

CAGR

6.7%

Largest Market

Asia-Pacific

Fastest Growing Market

Asia-Pacific

Pharmaceutical CDMO Market Dynamics

As the population increases and the number of regional markets entering the global landscape continues to increase, drug companies are feeling pressure to bring drugs to market more rapidly. CDMO outsourcing remains a key strategy for easing the pressures of development. In particular, API manufacturing has kept a firm position as the most outsourced area for drug manufacturers. This has led to healthy growth related with the sector, which is likely to steadily rise, especially over the short term. Pharma companies often need to access specialised manufacturing resources, facilities and capabilities to progress a drug from development through to commercial production. The outsourcing landscape is very fragmented and highly competitive, with a wide range of full service and niche contract development and manufacturing organisations (CDMOs) to choose from, as well as pure play and embedded CDMOs. The embedded CDMO is a unique option within the pharma and biopharma outsourcing space.

Global Pharmaceutical Contract Development And Manufacturing Organization Cdmo Market Segmentation Analysis

Report Benchmarks

Details

Report Study Period

2024-2030

Market CAGR

6.7%

By Service

  • Pharmaceutical Manufacturing Services
  • Pharmaceutical FDF Manufacturing Services
    • Tablet Manufacturing Services
    • Capsule Manufacturing Services
    • Oral Liquid Manufacturing Services
    • Parenteral/Injectable Manufacturing Services
    • Other Formulations
  • Pharmaceutical API Manufacturing Services
  • Drug Development Services
  • Biologics Manufacturing Services
  • Biologics FDF Manufacturing Services
  • Biologics API Manufacturing Services

By End User

  • Small & Mid-Size Pharma
  • Generic Pharmaceutical Companies
  • Big Pharma
  • Other End Users

Key Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2019-2023), and forecast (2024-2030)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments, and start-up details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario
  • The report analyses the impact of the socio-political environment through PESTLE Analysis and competition through Porter's Five Force Analysis

Download Free Sample Report

Frequently Asked Questions

The pharmaceutical cdmo market is projected to expand at a CAGR of 6.7% during the forecast period

Thermo Fisher Scientific Inc, Vetter Pharma International, Lonza Group, Recipharm AB, Catalent

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

Pharmaceutical Contract Development And Manufacturing Organization Market size was valued at 92.1 billion in 2022 and is expected to reach 145.0 million by 2029.

Author image

Author

Muni Kumar Meravath

Muni Kumar Meravath is a seasoned Healthcare Market Research Analyst with over 6 years of experience in the healthc.....

  1. Executive Summary
  2. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Introduction
    • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Taxonomy
    • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Definitions
      • Service
      • End User
  3. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics
    • Drivers
    • Restraints
    • Opportunities/Unmet Needs of the Market
    • Trends
    • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamic Factors - Impact Analysis
    • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Competition Landscape
  4. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029
    • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Year-over-Year (Y-o-Y) Growth Analysis (%)
    • Market Opportunity Analysis
  5. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market, By Service, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Pharmaceutical Manufacturing Services
      • Pharmaceutical FDF Manufacturing Services
        • Tablet Manufacturing Services
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Capsule Manufacturing Services
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Oral Liquid Manufacturing Services
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Parenteral/Injectable Manufacturing Services
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Other Formulations
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Drug Development Services
          • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
          • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
          • Market Opportunity Analysis
        • Biologics Manufacturing Services
          • Biologics FDF Manufacturing Services
            • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
          • Biologics API Manufacturing Services
            • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
            • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
            • Market Opportunity Analysis
  1. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast, By End User, 2018 - 2022 and Forecast, 2023 - 2029
    • Small & Mid-Size Pharma
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Generic Pharmaceutical Companies
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Big Pharma
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Other End Users
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
  1. Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Forecast, By Region, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • North America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Europe
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Asia-Pacific
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Latin America
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Middle East and Africa
      • Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
      • Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)
      • Market Opportunity Analysis
    • Global Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Opportunity Analysis Index, By Service, End User and Region, 2023 - 2029
  2. North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Service Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pharmaceutical Manufacturing Services
        • Pharmaceutical FDF Manufacturing Services
          • Tablet Manufacturing Services
          • Capsule Manufacturing Services
          • Oral Liquid Manufacturing Services
          • Parenteral/Injectable Manufacturing Services
          • Other Formulations
        • Pharmaceutical API Manufacturing Services
      • Drug Development Services
      • Biologics Manufacturing Services
        • Biologics FDF Manufacturing Services
        • Biologics API Manufacturing Services
      • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Small & Mid-Size Pharma
        • Generic Pharmaceutical Companies
        • Big Pharma
        • Other End Users
      • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • US
        • Canada
      • North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Opportunity Analysis Index, By Service, End User and Country, 2023 - 2029
      • North America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics - Trends
  1. Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Service Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pharmaceutical Manufacturing Services
        • Pharmaceutical FDF Manufacturing Services
          • Tablet Manufacturing Services
          • Capsule Manufacturing Services
          • Oral Liquid Manufacturing Services
          • Parenteral/Injectable Manufacturing Services
          • Other Formulations
        • Pharmaceutical API Manufacturing Services
      • Drug Development Services
      • Biologics Manufacturing Services
        • Biologics FDF Manufacturing Services
        • Biologics API Manufacturing Services
      • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Small & Mid-Size Pharma
        • Generic Pharmaceutical Companies
        • Big Pharma
        • Other End Users
      • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Germany
        • UK
        • France
        • Spain
        • Italy
        • Russia
        • Poland
        • Rest of Europe
      • Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Opportunity Analysis Index, By Service, End User and Country, 2023 - 2029
      • Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics - Trends
  1. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Service Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pharmaceutical Manufacturing Services
        • Pharmaceutical FDF Manufacturing Services
          • Tablet Manufacturing Services
          • Capsule Manufacturing Services
          • Oral Liquid Manufacturing Services
          • Parenteral/Injectable Manufacturing Services
          • Other Formulations
        • Pharmaceutical API Manufacturing Services
      • Drug Development Services
      • Biologics Manufacturing Services
        • Biologics FDF Manufacturing Services
        • Biologics API Manufacturing Services
      • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Small & Mid-Size Pharma
        • Generic Pharmaceutical Companies
        • Big Pharma
        • Other End Users
      • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Japan
        • China
        • India
        • ASEAN
        • Australia & New Zealand
        • Rest of Asia-Pacific
      • Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Opportunity Analysis Index, By Service, End User and Country, 2023 - 2029
      • Asia-Pacific Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics - Trends
  1. Latin America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Service Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pharmaceutical Manufacturing Services
        • Pharmaceutical FDF Manufacturing Services
          • Tablet Manufacturing Services
          • Capsule Manufacturing Services
          • Oral Liquid Manufacturing Services
          • Parenteral/Injectable Manufacturing Services
          • Other Formulations
        • Pharmaceutical API Manufacturing Services
      • Drug Development Services
      • Biologics Manufacturing Services
        • Biologics FDF Manufacturing Services
        • Biologics API Manufacturing Services
      • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Small & Mid-Size Pharma
        • Generic Pharmaceutical Companies
        • Big Pharma
        • Other End Users
      • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • Latin America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Opportunity Analysis Index, By Service, End User and Country, 2023 - 2029
      • Latin America Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics - Trends
  1. Middle East and Africa Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Analysis, 2018 - 2022 and Forecast, 2023 - 2029 (Revenue, USD Mn)
    • Service Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%), and Market Share (%)
      • Pharmaceutical Manufacturing Services
        • Pharmaceutical FDF Manufacturing Services
          • Tablet Manufacturing Services
          • Capsule Manufacturing Services
          • Oral Liquid Manufacturing Services
          • Parenteral/Injectable Manufacturing Services
          • Other Formulations
        • Pharmaceutical API Manufacturing Services
      • Drug Development Services
      • Biologics Manufacturing Services
        • Biologics FDF Manufacturing Services
        • Biologics API Manufacturing Services
      • End User Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn), Y-o-Y Growth (%) and Market Share (%)
        • Small & Mid-Size Pharma
        • Generic Pharmaceutical Companies
        • Big Pharma
        • Other End Users
      • Country Analysis 2018 - 2022 and Forecast 2023 - 2029 by Revenue (USD Mn) Y-o-Y Growth (%) and Market Share (%)
        • Gulf Cooperation Council (GCC) Countries
        • Israel
        • South Africa
        • Rest of MEA
      • MEA Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market - Opportunity Analysis Index, By Service, End User and Country, 2023 - 2029
      • MEA Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market Dynamics - Trends
  1. Competition Landscape
    • Strategic Dashboard of Top Market Players
    • Company Profiles (Introduction, Financial Analysis, End User & Service Offerings, Key Developments, Strategies, and SWOT Analysis)
      • Thermo Fisher Scientific Inc. (US)
      • Catalent (US)
      • Lonza Group (Switzerland)
      • Recipharm AB (Sweden)
      • Vetter Pharma International GMBH (Germany)
      • FAMAR Health Care Services (Greece)
      • AbbVie (US)
      • Aenova Group (Germany)
      • Consort Medical (UK)
      • Almac Group (UK)
      • Siegfried Holding AG (Switzerland)
      • Boehringer Ingelheim International GmbH (Germany)
      • Evonik Industries AG (Germany)
  1. Research Methodology
  2. Key Assumptions and Acronyms

Key Market Players

  • Thermo Fisher Scientific Inc. (US)
  • Catalent (US)
  • Lonza Group (Switzerland)
  • Recipharm AB (Sweden)
  • Vetter Pharma International GMBH (Germany)
  • FAMAR Health Care Services (Greece)
  • AbbVie (US)
  • Aenova Group (Germany)
  • Consort Medical (UK)
  • Almac Group (UK)
  • Siegfried Holding AG (Switzerland)
  • Boehringer Ingelheim International GmbH (Germany)
  • Evonik Industries AG (Germany)

Related Industry Reports